SPOTLIGHT -
AOA 2023: Investigating 3-layer amniotic membrane graft as an emerging treatment for ocular surface disease
Harmin Chima, OD, met with Optometry Times to discuss treatment options for ocular surface disease with Biovance's 3-layer amniotic membrane graft.